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Abstract
Background: Methylmecury (MeHg) is a widely distributed environmental pollutant with considerable risk to both
human health and wildlife. To gain better insight into the underlying mechanisms of MeHg-mediated toxicity, we
have used label-free quantitative mass spectrometry to analyze the liver proteome of Atlantic cod (Gadus morhua)
exposed in vivo to MeHg (0, 0.5, 2 mg/kg body weight) for 2 weeks.
Results: Out of a toltal of 1143 proteins quantified, 125 proteins were differentially regulated between MeHg-treated
samples and controls. Using various bioinformatics tools, we performed gene ontology, pathway and network
enrichment analysis, which indicated that proteins and pathways mainly related to energy metabolism, antioxidant
defense, cytoskeleton remodeling, and protein synthesis were regulated in the hepatic proteome after MeHg exposure.
Comparison with previous gene expression data strengthened these results, and further supported that MeHg
predominantly affects many energy metabolism pathways, presumably through its strong induction of oxidative
stress. Some enzymes known to have functionally important oxidation-sensitive cysteine residues in other animals
are among the differentially regulated proteins, suggesting their modulations by MeHg-induced oxidative stress.
Integrated analysis of the proteomics dataset combined with previous gene expression dataset showed a more
pronounced effect of MeHg on amino acid, glucose and fatty acid metabolic pathways, and suggested possible
interactions of the cellular energy metabolism and antioxidant defense pathways.
Conclusions: MeHg disrupts mainly redox homeostasis and energy generating metabolic pathways in cod liver.
The energy pathways appear to be modulated through MeHg-induced oxidative stress, possibly mediated by
oxidation sensitive enzymes.
Background
Mercury is released into the environment from both nat-
ural and anthropogenic sources, and occurs in different
chemical forms in the environment, such as elemental
mercury, inorganic mercury, and also as more toxic or-
ganic mercury compounds. The different forms of mer-
cury can be interconverted in a global mercury cycle
between the aquatic systems and the atmosphere [1].
Methylmercury (MeHg), which is an organic compound,
is formed from inorganic mercury in the aquatic environ-
ment by anaerobic bacteria [2]. In aquatic environments,
MeHg tends to bioconcentrate and bioaccumulate in or-
ganisms, and it has an extremely high potential for bio-
magnification up the food-chain [3]. MeHg can therefore
affect the health of both aquatic animals and humans, as
humans can be exposed to MeHg through consumption
of fish and other seafood. Because of safety concerns, food
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safety authorities often issue guidelines for the public to
avoid or limit the consumption of some fish species from
contaminated environments or with high muscle mercury
levels [3].
MeHg is highly toxic to animal tissues and organs, es-
pecially the brain [1, 4, 5]. Its neurotoxic properties are
partly due to its easy transport throughout the body, in-
cluding the blood–brain and blood-placental barriers, as
a complex with cysteine [4]. The MeHg–L-cysteine com-
plex has a similar structure as methionine and can be
transported across cellular membranes by L-type amino
acid transporters [6]. Its neurotoxic effects have been
well documented from tragic human poisoning incidents
in Japan (Minamata Bay) and Iraq (rural areas), and also
from controlled laboratory experiments [5, 7, 8]. Despite
the focus of many studies on the brain where most ser-
ious effects are elicited, MeHg affects other animal or-
gans and tissues as well [1, 4, 5]. For example, in fish,
effects on other tissues such as the liver and kidney
have been observed [9, 10]. Further, a recent epidemio-
logical study has reported associations between blood
mercury levels and changes in liver enzymes [11].
Among the main cellular effects caused by MeHg are
oxidative damage and mitochondrial dysfunction, dis-
ruption of Ca2+ homeostasis, apoptosis, inhibition of
microtubule assembly, and inhibition of protein synthe-
sis [5, 12–16].
The underlying molecular mechanism of MeHg toxicity
seems to be related to its ability to bind thiol-groups
present in biological molecules, including proteins. This
may lead to disruption of enzymatic functions, and particu-
larly inactivation of antioxidant systems, thereby promoting
generation of reactive oxygen species (ROS) [12, 13]. React-
ive thiol-groups of antioxidants such as glutathione and
proteins in the antioxidant defense systems are known tar-
gets of MeHg-induced oxidation [13]. Indeed, MeHg has
been shown to inhibit components in the two major anti-
oxidant defense pathways, the thioredoxin and glutaredoxin
enzyme systems [17–19]. Compromised antioxidant
defense can potentially result in severe oxidative damage to
sensitive proteins, and thus affecting related pathways.
Analyses of gene expression and proteomic responses
are increasingly useful in studying the effects and tox-
icity mechanisms of environmental contaminants [20].
Quantitative proteomics approaches for mapping mo-
lecular targets of toxicants may lead to a better under-
standing of the molecular mechanisms of toxicity and
discovery of new biomarkers [21]. Recent studies using
proteomics have reported that MeHg causes alterations
of proteins and pathways related to antioxidant defense
mechanisms, energy metabolism, and the cytoskeleton
in various organs and cells in both mammals [22, 23]
and fish [24–27]. These studies suggest that MeHg has
similar molecular mechanisms of toxicity in various
tissues of different animal species. Although the liver is
the most important organ in metabolism and detoxifica-
tion of environmental chemicals, it has not been well
investigated as a target organ of MeHg toxicity, particu-
larly by large-scale proteomics approaches.
The Atlantic cod (Gadus morhua) is a commercially
important species, but increasingly susceptible to marine
pollution from sources such as shipping activities, urban
effluent discharges, and discharges from offshore petrol-
eum industries. Importantly, Atlantic cod is increasingly
becoming a useful model organism to investigate effects
of contaminants, and as a sentinel species used in envir-
onmental monitoring of marine pollution [28–34]. It is
one of few fish species with a sequenced and annotated
genome [35], thus opening the possibility of using omics
methods in molecular toxicological studies [25, 36, 37].
The aim of this study was to investigate the molecular
targets and mechanisms of toxicity of MeHg on the liver
proteome of Atlantic cod. In our previous work, global
hepatic gene expression analysis with microarrays was
used to study the effect of MeHg on gene expression
using the same samples [37]. As part of an integrated
approach using both transcriptomics and proteomics, we
have in this study performed label-free mass spectrom-
etry analysis of the liver proteomes of cod exposed in
vivo to 0, 0.5 and 2 mg/kg body weight MeHg. In the
present study, 125 differentially regulated proteins were
identified, and functional enrichment analysis showed
that oxidative-stress responses and energy pathways
were among the most affected by the MeHg treatment.
These findings are in line with our previous gene expres-
sion data, and further suggest that MeHg may cause vul-
nerabilities of cellular energy pathways to oxidative
stress.
Results and discussion
Fish exposure, survival and condition factor
To examine dose–response effects of MeHg on Atlantic
cod, an in vivo exposure experiment with vehicle control
and three different doses of MeHg (0.5, 2 and 8 mg/kg
BW) were performed (n = 10/group). All fish in the high-
est (8 mg/kg BW) dose group, and 1 fish from each of
the 0.5 and 2 mg dose groups, died by the end of the
14 days exposure time [24]. The lowest dose of MeHg
(0.5 mg/kg BW) was chosen based on approximates of
mercury levels in fish reported in some field studies. For
example, mean mercury concentrations of up to
0.46 mg/kg wet-weight were detected in fish caught in
the Northwest Atlantic Ocean, and up to 2.07 mg/kg
wet-weight in fish from the Mediterranean Sea have
been reported [38]. The maximum limits of Hg allowed
in fish and fish products for human consumption is 0.5
or 1 mg/kg wet-weight, depending on the species [39].
Previous chemical analysis of tissue concentrations of
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Hg in the fish studied here, showed accumulation in the
liver with average levels of 0.8 and 2.8 mg Hg/kg wet
weight for the 0.5 and 2 mg/kg BW MeHg doses, re-
spectively [24]. Higher Hg levels were detected in the
muscle with 0.9 and 4.7 mg/kg wet weight for 0.5 and
2 mg/kg BW doses, respectively [24], consistent with a
known tendency of MeHg to accumulate in muscle tissue
[28]. No significant changes were observed in behavioural
parameters such as overall activity and balance during the
2 weeks of MeHg exposure period [24]. There were small
significant decreases in body weight at the end of the ex-
periment in all groups, including the control (Additional
file 1: Figure S1A). Condition factor decreased only
slightly (not significant) in the treated groups (Additional
file 1: Figure S1B) and there were no significant differences
in liver-somatic indices between control and treated
groups (Additional file 1: Figure S1C). Although the slight
decrease in condition factor suggests some effects of the
treatment, the observed decrease in body weight does not
seem to be the main effect of MeHg treatment as it was
also observed in the control group (Additional file 1:
Figure S1A).
Differentially regulated proteins
Total liver protein samples from Atlantic cod exposed to
0, 0.5 or 2 mg/kg body weight MeHg were prepared and
subjected to label-free mass spectrometry analyses
followed by quantitative proteomics. A total of 125
proteins were differentially regulated between the high
dose (2 mg/kg BW) MeHg-treated samples and controls
(Additional file 2: Table S1). Peptide abundance values
in all the three groups were found to have very similar
profiles and resembled normal distributions (Additional
file 1: Figure S2) for the 1143 proteins quantified
(Additional file 3: Table S2). Among the 125 proteins
differentially regulated, 44 were up-regulated and 81
down regulated (Additional file 2: Table S1). Hierarchical
cluster analysis of the differentially regulated proteins
shows the relative abundance ratio (fold-changes relative
to control) of each protein in the individual samples
(Fig. 1a). The cluster analysis shows well-clustered high
dose samples separated from the other groups. However,
the low dose and control samples show less within group
clustering, and the two groups are less separated from
each other (Fig. 1a). Of note, in the matrix data used for
clustering and PCA, only 7 proteins were significantly
differentially regulated in the low dose group. The three-
dimensional PCA plot (Fig. 1b) shows a similar trend as
observed in the hierarchical cluster analysis. The high
dose samples are clearly clustered and separated apart
from the controls, while samples from the low MeHg
doses largely fall between high dose and control groups,
more scattered among the latter group (Fig. 1b).
Among the differentially regulated proteins, many
were previously shown to have redox-sensitive Cys-
residues in other studies. These include the thioredoxin
Fig. 1 Hierarchical clustering (a) and principal component analysis (PCA) (b) of proteins differentially regulated by MeHg. Rows represent log2-transformed
abundance ratio values of proteins, while columns represent individual cod liver samples (a). Three-dimensional PCA of normalised LC-MS/MS
data (b). Individual samples are labelled according to the experimental group that they belong to; green circles: controls; yellow squares:
0.5 mg/Kg BW (LD); red-brown triangles: 2.0 mg/Kg BW (HD) (a and b)
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enzyme system proteins [18], as well as proteins that are
part of the fatty acid metabolism pathways, such as
mitochondrial acyl-CoA dehydrogenases [40]. In
addition, chaperons, tubulin and hemoglobin subunits
were among the differentially regulated proteins between
MeHg-treated and control groups (Additional file 2:
Table S1), which is also in line with previous two-
dimensional gel electrophoresis analyses of the thiol-
proteome obtained from the same liver samples [25].
The enzymes glutamine synthetase (GLNA) and
sodium-potassium ATPase (AT1B1), which decreased in
abundance after MeHg exposure (Additional file 2: Table
S1), were previously reported to have decreased activity
after MeHg-induced oxidative stress in rat brain, and
these effects were mitigated by antioxidants [41]. An-
other enzyme, tryptophan 2,3-dioxygenase (T23O), up-
regulated in MeHg-treated samples (also confirmed by
SRM) (Additional file 2: Table S1, Fig. 2a), has previously
been shown to have increased activity in mercuric chlor-
ide treated rat liver [42]. An enzyme in the cysteine and
methionine metabolism pathway, S-adenosylmethionine
synthase isoform type-2 (METK2) increased its
abundance in cod liver after MeHg treatment
(Additional file 2: Table S1). METK2 has been shown to
be important in oxidative stress responses [43]. Methio-
nine adenosyltransferases have oxidation-sensitive Cys-
residues, and they have been shown to be redox
regulated [44].
Some of the proteins and enzymes in the cod liver that
responded to MeHg exposure have previously been asso-
ciated with different human diseases. For instance, one
of the proteins that increased the most after MeHg ex-
posure, T23O (Additional file 2: Table S1, Fig. 2a) was
reported to have increased abundance in the brain of pa-
tients with schizophrenia and Alzheimer’s disease (AD)
[45, 46]. T23O is a rate limiting-enzyme in the trypto-
phan degradation pathway, and regulates the levels of
the amino acid tryptophan in the body. Apolipoprotein
E (ApoE) variants and other cholesterol-related genes
have been associated with the pathogenesis of AD [47].
The protein levels of APOB, APOE, APOC1 and APOA4
decreased in the high dose MeHg-treated fish liver
(Additional file 2: Table S1). It has been shown that
genetic ablation of Apoa4 gene in a mouse model
Fig. 2 SRM validation of differential protein expression. Peptides corresponding to the indicated proteins (shown here) were quantified using SRM for
individual samples in each of control (n = 10), 0.5 mg/kg BW MeHg (n = 9) and 2 mg/kg BW MeHg (n = 9) groups. a) T23O; VFVDLFNLATFLIPR.
b) GLNA; RPSANCDPYAVTEALIR. c) EPS8L2; DVQILNCALDDIELLVAR. d) APOA4; LTVNTQDLQSQLAELWK. e) RAP1B; LQIWDTAGQER. Differences
between control and treated groups were compared using Student's t test (*p < 0.05, **p < 0.01, and ***p < 0.001). Data are presented as
mean ± standard deviation, and the y-axis represents the ratio of intensities between the endogenous peptide (L) and the corresponding
isotopically labeled peptide that was added to the sample (H)
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accelerated the development of AD [48]. The differential
regulation of the products of the genes previously associ-
ated with the AD appears to support the hypothesis that
environmental chemicals such as MeHg may contribute
to its etiology [49]).
Levels of the antioxidant proteins glutaredoxin-1
(GLRX1) and peroxiredoxin-2 (PRDX2), belonging to
the glutaredoxin and thioredoxin antioxidant systems,
respectively, decreased after MeHg exposure (Additional
file 2: Table S1). The decrease in GLRX1 and PRDX2 ap-
pears to be in agreement with other studies demonstrat-
ing decreased enzymatic activities of the antioxidant
enzyme systems caused by MeHg-induced oxidation of
their Cys residues [17–19]. PRDX2 is a thiol-specific
antioxidant protein known to be modified upon oxida-
tion [50]. All proteins in the GO molecular function
“antioxidant activity” (GSTO1, GSTT1, GSTT2, PRDX2,
APOE and APOA4) (Table 1B, Additional file 4:
Table S3) had lower abundances in the high dose
MeHg exposed group (Additional file 2: Table S1).
Furthermore, GST activity was measured in the individual
liver homogenates using a GST assay, and in line with the
proteomics data, the GST activity decreased with increas-
ing MeHg exposure (Fig. 3). Decreased activities of some
antioxidant enzymes, including GSTs, have previously
been shown to be positively correlated with mercury con-
tamination in fish [51, 52]. Intriguingly, GSTT1 was up-
regulated at the mRNA level in the same liver samples
[37]. The reason for this discordance is not clear, but it
might be due to oxidation-related post-translational modi-
fications and possible degradation of the protein. It is
known that oxidatively modified and damaged proteins
undergo degradation in the cell [53]. Another thiol oxida-
tion sensitive enzyme, glutamine synthetase (GLNA)
(down regulated here) (Fig. 2b), was previously shown to
be degraded upon oxidation [54]. The binding of MeHg
to thiol groups of proteins (S-mercuration) can lead
to their inactivation and aggregation [55]. Indeed, this
property has been used to precipitate and identify another
protein, sorbitol dehydrogenase (DHSO), which contains
reactive Cys residues [56]. DHSO decreased in abundance
in cod liver after MeHg treatment (Additional file 2:
Table S1). The enzyme GAPDH (G3P) also decreased
its abundance in cod liver after MeHg exposure (Additional
file 2: Table S1). It has been shown that GAPDH can be ox-
idized at its active site Cys residue, resulting in misfolding
and inactivation [57, 58]. Occurrence of misfolding and
conformational changes of proteins was suggested by en-
richment of the unfolded protein response (UPR) pathway
observed in comprehensive transcriptome analysis of the
same samples [37]. Among the up-regulated chaperone
transcripts was GRP78 (78 kDa glucose-regulated protein),
which is a key regulator of UPR [59]. Activation of UPR
can trigger degradation of misfolded proteins and
Table 1 The top significantly enriched GO BP, MF and
MetaCore “Process Networks” annotationsa
# A) GO processes In data FDR
1 Small molecule metabolic process 56 2.049E-11
2 Response to inorganic substance 29 4.840E-10
3 Macromolecular complex remodeling 10 4.840E-10
4 Plasma lipoprotein particle remodeling 10 4.840E-10
5 Protein-lipid complex remodeling 10 4.840E-10
6 Cholesterol efflux 10 1.124E-09
7 Glycerolipid catabolic process 11 1.124E-09
8 Single-organism metabolic process 76 1.931E-09
9 Metabolic process 121 1.931E-09
10 Plasma lipoprotein particle organization 10 2.287E-09
# B) GO Molecular functions In Data FDR
1 Oxidoreductase activity 19 7.654E-04




4 Small molecule binding 37 7.654E-04
5 Cholesterol transporter activity 4 7.654E-04
6 Sterol transporter activity 4 7.654E-04
7 Antioxidant activity 6 7.654E-04
8 Poly(A) RNA binding 21 1.899E-03
9 Anion binding 36 2.555E-03
10 Nucleotide binding 32 2.621E-03
# C) Process Networks In Data FDR
1 Translation_Translation initiation 9 1.001E-02
2 Response to hypoxia and oxidative stress 8 1.999E-02
3 Cytoskeleton_Actin filaments 8 2.223E-02
4 Cell adhesion_Cell junctions 7 4.893E-02
aOnly the top 10 enriched GO BP (A) and MF (B) are shown here, and the full
list of top 50 significantly enriched (FDR < 0.05) GO BP and MF terms and the
associated proteins are presented in Additional file 4: Table S3
*
Fig. 3 Enzymatic activity of glutathione (GST) in liver homogenates.
GST activity was measured in liver homogenate in each of control
(n = 10), 0.5 mg/kg BW MeHg (n = 9) and 2 mg/kg BW MeHg (n = 9)
groups. Differences between control and treated groups were
compared using Student's t test (*p < 0.05). Data are expressed as
mean (GST activity per min per mg protein) ± standard deviation
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suppression of protein translation [59]. Thus, it is possible
that the decreasing levels of some antioxidant enzymes
and other proteins observed in this study are related to
MeHg-induced conformational changes, possibly resulting
in aggregation and degradation. Some studies suggest that
an overwhelmed antioxidant defense system may lead
to decreased activity of antioxidant enzymes such as
GSTs [52, 60].
Selected reaction monitoring (SRM)
To verify the label-free quantitative proteomics data, six
proteins (T23O, GLNA EPS8L2, APOA4, RAP1B,
CATZ) among the top differentially regulated were se-
lected and quantified with the more specific SRM
method. At least one peptide originating from each of
the six selected proteins was quantified using SRM. Pep-
tides from five of the selected proteins (T23O, GLNA
EPS8L2, APOA4, RAP1B) showed significant changes in
the SRM analyses in agreement with the label-free quan-
tification (Fig. 2a-e, Additional file 2: Table S1). Three
other SRM-quantified peptides selected for the APOA4
protein also showed significant decreases (Additional file 1:
Figure S3A-C), similar to the 4th peptide shown in Fig. 2d.
The peptide for cathepsin Z (CATZ), which was found to
have increased levels in MeHg-treated samples with the
label-free method (Additional file 2: Table S1), did not
change significantly using the SRM method (Additional
file 1: Figure S3D). Thus, the SRM data showed largely
good concordance with the label-free quantitation, con-
firming reliability of the quantitative data generated by
the latter method.
Biomarker candidates
Quantitative proteomics studies may help to identify
proteins that can be used as biomarkers in mechanistic
toxicological studies and environmental pollution moni-
toring. In this regard, using label-free quantitative prote-
omics in the discovery phase for identifying altered
proteins, followed by verification with SRM, can be a
useful method in identification and quantification of po-
tential biomarker proteins. Verification of differentially
regulated candidate biomarkers by the SRM method is
particularly useful when antibodies are unavailable for
quantification of the proteins of interest by immuno-
logical methods, such as Western blotting and ELISA.
Discriminant analyses using the five proteins verified
by SRM in this study were performed in order to investi-
gate their discriminating power between the controls
and MeHg-exposed samples. The conjoint expression
profile of these five proteins was able to discriminate be-
tween the controls and the samples exposed to the high-
est dose of MeHg (not shown). Furthermore, by using a
stepwise variable selection in the discriminant analyses,
the addition of three more proteins (FLNA, GTR2,
OCM2) was sufficient to also separate the low-dose
MeHg samples from the controls without any misclassi-
fication (Fig. 4). Some of these eight proteins, and a few
others found differentially regulated in the label-free
proteomics analyses, may be evaluated as potential bio-
markers of hepatic MeHg exposure in future studies. For
example, among the 5 proteins validated by SRM, GLNA
and T23O have been reported to be modulated by mer-
cury exposure, as mentioned above, although these ef-
fects appear to be related to oxidative stress [41, 42],
and it is not clear if they are specific to mercury
exposure.
A more promising biomarker candidate of particular
interest is the enzyme uroporphyrinogen decarboxylase
(DCUP/UROD), found down regulated here (Additional




Fig. 4 Stepwise discriminant analysis differentially regulated proteins. A set of 8 proteins (five of them confirmed by SRM) correctly classified all
28 individual samples into the three groups. Circles indicate 95 % confidence limits for the group means. Non-intersecting circles indicate
significantly different groups
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biosynthetic pathway and decreased activity of DCUP
has been associated with the human diseases porphyria
and liver damage [61]. It has been shown that MeHg in-
hibits DCUP in rat kidney, leading to increased porphy-
rin excretion [62]. The urinary porphyrin excretion
profile was specific to mercury compounds, and thus it
was suggested as a specific biomarker of mercury expos-
ure [62]. Therefore, down regulation of UROD in MeHg
treated cod makes it a strong candidate as a biomarker
of MeHg exposure. Liver and blood UROD activity and
porphyrin profile might be evaluated as biomarkers for
MeHg exposure in fish. Down regulation of other pro-
teins involved in heme metabolism such as heme-
binding protein 2 (HEBP2) and biliverdin reductase B
(BLVRB) (Additional file 2: Table S1) also suggest per-
turbation of heme homeostasis in MeHg treated cod
liver. Consistent with our results, lower liver UROD ac-
tivities and increased porphyrin levels were detected in
pike from River Rhine polluted with halogenated hydro-
carbons and heavy metals including mercury [63]. How-
ever, UROD activity and porphyrin profiles are not
commonly used as biomarkers in fish [64], and our re-
sults encourage further potential for development. Aryl
hydrocarbon receptor agonist halogenated hydrocarbons
have been shown to induce prorphyrin accumulation in
the fish hepatoma cell line (PLHC-1) [65]. Thus, in fur-
ther experiments, changes in expression and activity of
UROD combined with porphyrin profile may be per-
formed to evaluate the specificity of responses to mer-
cury exposure in hepatoma cell line [65] and in ex vivo
systems such as precision-cut liver slices [66].
Enriched pathways
Annotation and enrichment analysis of the differentially
regulated proteins (Additional file 2: Table S1) was per-
formed using MetaCore software and database. GO
terms and MetaCore “Process Networks” highlight en-
richment of different energy metabolisms (particularly
lipid metabolism), antioxidant defense, translation, cyto-
skeleton remodelling, and cell adhesion related pathways
(Table 1A-C, Additional file 4: Table S3). The top GO
BP term “small molecule metabolic process” contains
proteins in the metabolism of lipids (e.g. PLA2, POA4,
APOE), amino acids (e.g. MAT2A, GLNA, TDO2), car-
bohydrates (e.g. HXK2, RPIA), fatty acids (e.g. PECR,
ACDS), and antioxidant defense systems (e.g. GSTs,
PRDX2) (Additional file 2: Table S1, Additional file 4:
Table S3). Terms #3-7 and 10 in GO BP (Table 1A) are
redundant and largely related to plasma proteins. The
most significantly enriched GO MF term “oxidoreduc-
tase” contains proteins involved in both the antioxidant
defense systems (such as GSTs) and the energy path-
ways, such as ACADS and IDHP (IDH2) (Table 1B,
Additional file 4: Table S3). GO MF terms
“oxidoreductase activity” and “antioxidant activity”
(Table 1B) and process network “response to hypoxia
and oxidative stress” (Table 1C) share the antioxidant re-
sponse proteins GSTO1, GSTT1, GSTT2 and PRDX2
(Additional file 4: Table S3). Similarly proteins in the
process network “translation initiation“are a subset of
proteins in GO MF term “poly(A) RNA binding”
(Table 1C, Additional file 4: Table S3). Many of the
enriched pathways (Table 1A-B, Additional file 4:
Table S3) are also represented in networks of differen-
tially regulated proteins (Fig. 5, Additional file 1:
Figure S4, Additional file 5: Table S4) (see below). Fur-
ther, protein domain enrichment analysis in STRING
also resulted in significant enrichment (FDR < 0.05) of
the Interpro protein domain “thioredoxin-like fold”,
which is present in the 7 proteins GSTO1, GSTT1,
PRDX2, ERP44, TXNL1, GLRX and PRDX2 (Additional
file 1: Figure S4), thus supporting MeHg-mediated effects
on the antioxidant systems.
Enrichment of the energy pathways supports the ef-
fects of MeHg on these cellular processes, particularly
mitochondrial metabolic pathways as observed previ-
ously by gene expression analysis of the same samples
[37]. In the previous gene expression analysis, transcripts
of many mitochondrial enzymes, such as acyl-CoA dehy-
drogenases were particularly affected, suggesting specific
effects of MeHg-induced oxidative stress. Recently, Cys-
residues of many mitochondrial enzymes have been
shown to be oxidized upon Cadmium-induced oxidative
stress in mouse liver [40]. Notably, Cys residues of some
of the proteins differentially regulated here (ACADS,
GLNA, IDHP/IDH2, ERP44, PECR and TRFE)
(Additional file 2: Table S1), were found to be differen-
tially oxidized in the Cd-treated mouse liver samples
[40]. Among these, ACADS, IDHP/IDH2 and PECR are
enzymes that are part of cellular energy pathways. Im-
portantly, ERP44 is a multifunctional chaperone with a
Cys-residue that is critical for its function in quality control
of proteins in the early secretory pathway, redox homeosta-
sis, and regulation of calcium flux [67]. In our previous
transcriptome analysis of the same samples, we also ob-
served differential regulation of several genes participating
in different energy pathways, particularly the fatty acid and
amino acid metabolic pathways [37]. The similar responses
to cadmium chloride and MeHg suggest that differential
regulation of the genes or proteins are mediated by induc-
tion of oxidative stress by these compounds.
Mitochondrial energy generating pathways (electron-
transport chain and fatty acid beta-oxidation) were found
to be affected by HgCl2 in zebrafish liver [68], which is also
in agreement with our results. Similarly, proteins that are
part of the antioxidant defense and energy pathways were
modulated in Atlantic salmon fed with a MeHg-containing
diet [26]. Moreover, energy and redox pathways were also
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affected in the brain, demonstrated by two-dimensional gel
electrophoresis analysis of the brain proteome of Atlantic
cod [24] as well as transcriptomics studies of zebrafish [27].
Recently, by proteomics analysis, it was also reported that
chronic exposure to low doses of MeHg resulted in down-
regulation of energy pathway proteins and metabolic deficit
in the somatosensory cortex of the rat brain [22]. In an-
other recent proteomics study of the brain of common
marmosets, proteins involved in the metabolism of carbo-
hydrate derivatives were found to be down regulated, sug-
gesting negative effects of MeHg on the carbohydrate
metabolism [23]. Taken together, these results strongly sug-
gest that oxidative stress mediated effects on energy path-
ways is a general mechanism of MeHg-mediated toxicity.
Comparison of proteomics and gene expression data
Comparison of significantly enriched (FDR < 0.05) top 50
annotations (GO BP, MF and MetaCore process networks)
between the trancriptomics [37] and proteomics data ob-
tained from the same cod liver samples showed many
shared pathways (Additional file 1: Figure S5). As ex-
pected, a higher number of genes (650 genes) were differ-
entially regulated in the microarray analysis compared to
the identified number of differentially regulated proteins
(125 proteins). However, twenty-six annotations were
shared between the two datasets. The main processes pre-
viously known to be affected by MeHg, such as energy
metabolism, oxidoreductase activities, protein translation,
and cytoskeleton remodelling, were enriched in both data-
sets, showing agreement between the two methods.
Although analysis of transcriptomics and proteomics
data revealed many shared pathways, only 11 genes were
present in both lists of differentially regulated genes and
proteins. Of these 11 genes, 6 showed concordance in
expression changes at mRNA and protein levels (genes
encoding ACADS, METK2, SCOT1, EPS8L2 and FUBP2
Fig. 5 Networks of differentially regulated proteins in MeHg treated samples. The networks were constructed in Cytoscape using CluePedia plug-in.
Enrichment analysis was performed using GO (BP and MF), KEGG, REACTOME and WikiPathways at FDR threshold of 0.05. Each group (GO term or
pathway) and associated proteins share same color, and node size indicates significance level. For full names of abbreviated of protein names and
synonyms, see Additional file 1: Table S1
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increased, while CATZ decreased). In contrast, genes en-
coding IDHP/IDH2, GSTT1, RL19 and TRI16 increased
at the mRNA levels and decreased at the protein levels.
The gene encoding LPP60 decreased at mRNA level and
increased at protein level. Thus, changes in 5 of the 11
proteins were not consistent with changes in mRNA
levels. The overall correlation for 32 common tran-
scripts/proteins detected at more relaxed differential
regulation cut-offs for transcripts (FDR < 5 % and mini-
mum 1.2 fold change) and proteins (p < 0.05) was low
(r = 0.16), with only 14 of them changing in the same
direction (not shown). The lack of strong correlation
between transcript and protein changes is not surpris-
ing. Numerous studies in various organisms reported
low to modest correlation between mRNA and protein
levels [69–71]. In mouse liver, not more than 50 % of
the genes showed a significant correlation of 0.27 be-
tween transcript and protein levels [69]. In a study
comparing transcript and protein expression responses
to a toxicant (2A-DNT) treatment, poor correlation
was observed, although higher order pathways affected
were similar [70]. Similarly, in our study proteomics
and transcriptomics datasets shared many GO annotations
despite low correlation at the individual transcript and
protein expression levels (Additional file 1: Figure S5).
Factors that may contribute to the low correlation may be
post-translational modifications, localization (ex. secreted
proteins), and different dynamics of mRNA and protein
turnover. As discussed above, degradation of some pro-
teins triggered by MeHg-induced oxidation could be one
factor contributing to low correlation between protein and
mRNA levels.
To further investigate integrated effects of MeHg in
the cod liver, we combined the differentially regulated
650 genes and the 125 proteins and performed network
analysis and enrichment of GO (BP and MF), KEGG,
Wikipathways, and REACTOME pathways using the
CluePedia application in Cytoscape. The generated net-
work highlights major processes and pathways affected,
including amino-acid metabolism, fatty-acid metabolism,
glucose metabolism and protein synthesis (Additional
file 1: Figure S6). The energy pathways dominate in the
combined dataset due to the high number of energy
pathway genes, particularly amino acid and fatty acid
metabolism genes represented in the larger transcripto-
mics dataset [37]. Processes and pathways mostly related
to oxidative stress such as sulphur compound metabol-
ism, glutathione metabolism and oxidation and reduc-
tion processes, and co-factor metabolism, are also
highlighted (Additional file 1: Figure S6). Notably, the
pentose phosphate pathway (PPP) that generates
NADPH required as electron donor in the antioxidant
systems is significantly enriched in the combined dataset
(Additional file 1: Figure S6).
Finally, comparison of GO BP and MF affected in MeHg
treated cod as determined by liver transcriptomics analysis
[37], liver proteomics (this study) and brain proteomics
(same fish as used in this study) [24] shows that processes
related to energy metabolism and oxidative responses
are shared among the three studies (Additional file 1:
Figure S7). For example, among the 12 significantly
enriched GO terms shared between the datasets, “small
molecule metabolic process” and “oxidoreductase activity”
are related to energy and redox pathways (Additional
file 1: Figure S7).
Other enriched pathways include pathways related to
translation, cytoskeleton, vesicle transport and choles-
terol transport (Table 1; Additional file 4: Table S3,
Additional file 1: Figure S4). Effects on protein synthe-
sis and the cytoskeleton were also observed in both
transcriptomics and proteomics analyses (Additional
file 4: Table S3, Additional file 1: Figure S4). It is not
clear if some of the enriched pathways are activated or
suppressed from our analysis as the differential regula-
tion of component proteins largely changed in both di-
rections (Additional file 1: Figure S4). For example,
some proteins involved in poly(A) RNA binding related
to translation increased and others decreased, and the
outcome on protein synthesis is not clear. However,
previous studies have reported that MeHg inhibits pro-
tein synthesis [5]. The enrichment of the cytoskeletal
assembly pathway is possibly related to the known
negative effect of MeHg on microtubule assembly [15].
Tubulin alpha and beta chains were also among the
polypeptides with reactive thiol groups identified in the
liver thiol proteome analysis of the same cod liver
samples [25].
Network analyses suggest possible interactions of
oxidative stress and energy pathways
Network analysis of the differentially regulated proteins
was performed in Cytoscape (http://www.cytoscape.org/)
using the Cluepedia plug-in [72]. Similar to the GO
terms and process networks enriched in the MetaCore
analysis (Table 1, Additional file 4: Table S3), the gener-
ated networks highlighted energy pathways (e.g. TCA
cycle and fatty acid beta oxidation) and antioxidant re-
sponses (e.g. phase II conjugation) (Fig. 5). Other path-
ways related to the significantly enriched GO terms
“vesicle-mediated transport” and “blood coagulation”
and “cadherin binding” (Additional file 4: Table S3) can
also be visualized in the Cytoscape network (Fig. 5).
Furthermore, protein-protein interaction network ana-
lysis of the differentially regulated proteins was per-
formed using the STRING database and web-tool
(http://string-db.org). STRING also enables enrichment
analysis and visualization of KEGG, GO and protein do-
mains in protein networks. Annotations consisting of 6
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KEGG pathways, 9 GO BP terms, 2 GO MF terms, 16
GO CC terms and 1 Interpro protein domain were sig-
nificantly enriched at FDR p-value < 0.05 (Additional
file 1: Figure S4, Additional file 5: Table S4).
The networks suggest interesting interactions of pro-
teins and pathways of energy metabolism and antioxi-
dant systems. Notably, the networks show separate
clustering of energy pathway (TCA cycle) proteins and
antioxidant response proteins (disulfide oxido-reductase
activity, phase II conjugation) linked by the mitochon-
drial isocitrate dehydrogenase enzyme (IDPH/IDH2)
node (Fig. 5). IDH2, that was down regulated in MeHg
exposed samples (Additional file 2: Table S1), is an en-
ergy pathway enzyme that is also a key component of
the antioxidant defense, being important in the NADPH
generation in the mitochondria [73]. NADPH is import-
ant in providing reducing potential to the glutaredoxin
and thioredoxin antioxidant systems. Although the con-
sequence of IDH2 down regulation on energy pathways
is unclear from our results, mitochondrial IDH2 func-
tion is known to be influenced by ROS [74], and it has
been suggested that its activity is specifically modulated
through oxidation of an important Cys-residue upon
oxidative stress [75]. Consistent with these previous re-
ports, our network analysis suggests that IDH2 could be
one of the links for interactions between antioxidant sys-
tems and energy pathways (Fig. 5). Indeed, recent studies
have shown that ROS levels can regulate the activities of
enzymes in the mitochondrial energy generating path-
ways through Cys thiol modifications [76].
Further, STRING protein-protein interaction networks
and enrichment analysis also suggest crosstalk between
energy pathways and redox homeostasis (Additional file
1: Figure S4). For example, ATP-citrate lyase (ACLY)
that is known to be redox-regulated [77], forms an im-
portant hub in STRING protein-protein interaction net-
work linked with many energy pathway and antioxidant
proteins (Additional file 1: Figure S4). Another hub is
formed by GAPDH, which is a glycolytic enzyme known
to be involved in antioxidant responses [78]. ACLY,
GAPDH and many energy pathway enzymes (e.g. TCA
cycle and fructose and mannose metabolism) were down
regulated in MeHg treated samples, suggesting suppres-
sion of the cellular energy pathways (Additional file 1:
Figure S4, Additional file 2: Table S1). Suppression of
the energy pathways is consistent with presence of react-
ive Cys residues in many of the energy pathway enzymes
discussed above that might make them targets of MeHg-
indued oxidation. Importantly, it has been reported that
oxidation of GAPDH enables the re-routing of metabolic
flux from glycolysis to the Pentose Phosphate Pathway
(PPP) in order to generate NADPH required for the
antioxidant systems [78]. This is another example of
redox modulation of an energy pathway. The PPP is one
of the significantly enriched carbohydrate metabolism
pathways in the combined transcriptomics and proteo-
mics dataset (Additional file 1: Figure S6), suggesting its
activation in response to increased oxidative stress.
These results provide some mechanistic insights into
how MeHg-induced oxidative stress might be disrupting
cellular redox balance and energy metabolism.
Recent studies have identified oxidation sensitive Cys
residues in many mitochondrial enzymes and suggest
modulatory effects of oxidative stress on the energy me-
tabolism [40, 79], which is consistent with our results. It
has been suggested that the interaction of redox and
metabolic pathways are coordinated by the transcription
factor nuclear factor erythroid 2-related factor (Nrf2),
which regulates transcription of genes in phase II and
phase III detoxification pathways, the antioxidant glutar-
edoxin and thioredoxin systems, and energy pathways,
including carbohydrate metabolism and NADPH gener-
ation [80]. In fact, many Nrf2 regulated genes were regu-
lated in our MeHg treated samples, and the Nrf2
regulatory pathway was significantly enriched in the
transcriptomics analysis [37]. Long established effects of
MeHg, such as mitochondrial dysfunction, altered
calcium homeostasis, and apoptosis, are thought to be
consequences of its oxidative stress promoting charac-
teristics [12, 13]. Although other studies have reported
effects of MeHg on energy pathways [22, 23, 27, 81], our
integrated transcriptomics and proteomics data indicate
more comprehensive effects of MeHg on major energy
pathways, in particular the mitochondrial fatty acid me-
tabolism. The apparently more coordinated effects ob-
served on energy metabolic pathways in our studies,
perhaps reflect the extent of the data (integrated tran-
scriptomics and proteomics) and the fact that the main
physiological role of the liver is metabolism. The overall
results indicate that oxidative stress may lead to pertur-
bations in energy pathways in cod liver, further support-
ing induction of oxidative stress as the underlying
mechanism of cytotoxic effects of MeHg. Although oxi-
dation of proteins is often reversible, persistent exposure
to MeHg may lead to irreversible oxidation of thiol
groups causing enzyme inactivation, mitochondrial dys-
function and other cellular damages.
Conclusions
Extensive proteomics analysis of liver samples from cod
treated with MeHg indicated oxidative stress responses
and perturbation of cellular energy pathways, confirming
our earlier findings by transcriptomics analysis. The in-
tegrated analyses with both transcriptomics and proteo-
mics data, together with previous studies, further
support that MeHg-induced oxidative stress modulates
cellular energy pathways, contributing to well-known
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toxic effects of this compound, such as mitochondrial
dysfunction and other cellular damages.
Methods
Fish exposure and sampling
Fish exposure and sampling has been described previ-
ously [24]. Briefly, juvenile Atlantic cod (G. morhua) of
mixed gender (body weight of 260–530 g) were divided
into four 500 L-tanks for control, 0.5, 2 and 8 mg/kg
groups (n = 10/group), and acclimated for 6 days in con-
tinuously running seawater (temperature 10 ° C and sal-
inity 34‰) at the facility in ILAB, Bergen, Norway. The
fish were fed daily with commercial pellets (Ewos marin
6 mm, EWOS, Bergen, Norway). Methylmercury chlor-
ide (CH3 HgCl) (Strem Chemicals, Newburyport, USA)
was dissolved in the vehicle (20 % acetone and 80 % soy-
bean oil). The vehicle (control), 0.5, 2 or 8 mg/kg body
weight methylmercury chloride was injected intraperito-
neally by inserting the needle carefully into the abdom-
inal cavity, not to puncture internal organs. The
indicated doses were divided into two and the first half
injected on day 1, and the second half after one week.
After the second injection all the fish in the highest
(8 mg) dose group and 1 fish from each of the 0.5 and
2 mg dose groups died. The fish were observed and be-
havioural parameters such as overall activity and balance
was registered during the exposure period. After 2 weeks
(14 days) the fish were sacrificed by decapitation and tis-
sue samples collected. Liver samples were dissected,
weighed and snap frozen in liquid nitrogen and stored at
−80 °C. The National Animal Research Authority ap-
proved the exposure experiment. Fish length (in cm)
and weight (in g) were recorded at the start and end of
the experiment. Condition factor (100 * weight/length3)
and liver-somatic index (100 * liver weight/BW) were
calculated, and Student's t-test was used to calculate
p-value between sample groups.
Sample preparation
Homogenization of liver samples has been described
previously [25]. Briefly, frozen individual cod liver sam-
ple obtained from each of control (n = 10), 0.5 mg/kg
BW MeHg (n = 9) and 2 mg/kg BW MeHg (n = 9)
groups (from 28 fish in total) was thawed on ice, washed
and homogenized in phosphate-buffered saline (PBS,
pH 7.4). The homogenate was centrifuged at 13,000 × g
for 10 min and the supernatant containing hepatic pro-
teins was digested with trypsin, and the resulting pep-
tides purified as described previously [82].
Label-free proteomics using LC-MS
The peptide sample (1 μg) from each of control (n = 10),
0.5 mg/kg BW MeHg (n = 9) and 2 mg/kg BW MeHg
(n = 9) groups was dissolved in 1 % aqueous formic acid
(FA) and injected into an Ultimate 3000 RSLC system
(Thermo Scientific) connected online to an LTQ-
Orbitrap Velos Pro mass spectrometer (Thermo Scien-
tific) equipped with a nanospray Flex ion source
(Thermo Scientific). The peptides were separated using
a 90 min HPLC gradient with increasing acetonitrile
concentration in 0.1 % FA and the acquisition time for
LC-MS data was 80 min as previously described [82].
The LTQ-Orbitrap Velos Pro settings were the same as
previously described [82] except that the normalized
collision energy was set to 35 % and the dynamic exclu-
sion to 30s.
Analysis of the label-free data using Progenesis LC-MS
Progenesis LC-MS® v4.1 (Nonlinear Dynamics Ltd)
was used for label-free quantification of automatically
aligned LC-MS data. Only peptide features with
charges between +2 to +5 containing the top 10
ranked MSMS spectra (with precursor intensities
more than 0) and where MSMS was executed on the
highest precursor isotopes (less than 6) were accepted.
The MSMS spectra list was sorted by rank and the
fragment ions in the MSMS spectra were limited to
200 allowing deisotoping and charge deconvolution
prior to export as an mgf file for identification. The
mgf file was searched using SearchGUI v1.18.1 [83]
using the option “Delete duplicate spectra titles”. The
search engines X!Tandem, MS Amanda and MS-GF+
Beta were used for searches in the Ensembl Gadus
morhua protein database. Protein identification was
conducted against a concatenated target/decoy version
of a complement of the database and the decoy
sequences were created by reversing the target
sequences in SearchGUI. The identification settings
were: trypsin with a maximum of 1 missed cleavages;
10 ppm as MS1 and 0.5 Da as MS2 tolerances; carba-
midomethyl Cys as fixed modification; oxidation of
Met as variable modification.
Peptides and proteins were inferred from the spectrum
identification results using PeptideShaker v0.28 [84].
Peptide Spectrum Matches (PSMs), peptides and pro-
teins were validated at a 1 % False Discovery Rate (FDR)
estimated using the decoy hit distribution. The results
were exported as validated PSMs and imported into Pro-
genesis. The sum of the normalized abundances of 1143
quantified unique proteins was exported from Progen-
esis and analyzed further using statistical analyses.
Proteomics data analysis
For functional annotation and pathway analysis, the
1143 unique cod proteins quantified (Additional file 3:
Table S2) were mapped to orthologs of human proteins
in Swissprot database using the BioMart tool in Ensembl
database (Ensembl.org) or BLAST searches in Swissprot
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database using the cod protein sequences. There are
22154 genes in the genome of Atlantic cod in the Ensembl
database (Ensembl.org). Differential expression analysis
was performed using one-way ANOVA followed by
Dunnett´s test (JMP, SAS Institute, Cary NC, USA). In
addition, we performed differential expression analysis
using SAM (Significance Analysis of Microarrays) imple-
mented in J-Express [85] (http://www.molmine.com/) that
enables estimation of False Discovery Rates (FDR) in pair-
wise comparisons. Proteins with p value < 0.05 (Dunnett´s
test) and FDR < 0.1 (SAM) satisfying a fold change
(treated/ control) greater than 1.2 or less than 0.8 were
considered differentially regulated. (Additional file 2:
Table S1). Although minimum fold change of 1.3-2 is
commonly used as cut-off for differential regulation in
quantitative proteomics [86], a minimum fold change
of 1.2 was used here, considering a relatively large
number of biological replicates analyzed (n = 9–10 per
group). Following these criteria, a total of 125 proteins
were identified as significantly differentially regulated
between the 2 mg/ kg BW MeHg dose and control
groups, of which 44 were up-regulated and 81 were
down regulated between controls and 2 mg/kg BW
MeHg treated samples (Additional file 2: Table S1).
Among the 125 proteins, 7 were differentially regulated
in both 0.5 mg and 2 mg/kg BW MeHg dose groups
(Additional file 2: Table S1) using the statistical criteria
stated above. No proteins were differentially regulated
exclusively in the low dose (0.5 mg/ kg BW) group.
Hierarchical clustering (complete-linkage) and principal
component analysis (PCA) of proteins differentially
regulated by MeHg was performed based on log2-
transformed abundance ratio values and arcSinh nor-
malised protein abundances, respectively (JMP 11, SAS
Institute, Cary NC, USA). Discriminant analyses were
performed on arcSinh normalised protein abundances
using the Linear method and stepwise variable selection
in JMP 11.
Selected reacting monitoring (SRM)
SRM was performed for six proteins (T23O, GLNA
EPS8L2, APOA4, RAP1B, CATZ) among the top differ-
entially regulated. As certain criteria, such as peptide
length, protease miscleavage, and amino acid compos-
ition must be considered when selecting peptides for
SRM analyses, it was not possible to choose freely from
the list of proteins/peptides quantified with the label-
free approach. Stable isotope –labelled synthetic pep-
tides (SIS) were purchased in crude quality from
Thermo Scientific. The C-terminal lysine or arginine in
the SIS peptides were replaced by isotope-labelled lysine
(13C6,
15N2) or arginine (
13C6,
15N4), resulting in a mass
difference of 8 Da and 10 Da, respectively, to the corre-
sponding endogenous peptide. The SIS peptides were
spiked in equal amounts into the digested protein sam-
ples, at approximately the same level as the endogens
peptide, prior to desalting with Oasis HLB μElution
Plate (Waters). A Q-Trap 5500 (AB SCIEX) connected
to a Dionex Ultimate NCR-3500RS LC system was used
for the LC SRM analyses. The protein digest were dis-
solved in 2 % ACN, 0.1%FA (Buffer A) and 1 μg peptides
was trapped on the pre-column (Dionex, Acclaim
PepMap 100, 2 cm x 75 μm i.d, 3 μm C18 beads) in buf-
fer A at a flowrate of 5 μl/min for 5 min before separ-
ation by reverse phase chromatography (Dionex,
Acclaim PepMap 100, 15 cm x 75 μm i.d., 3 μm C18
beads) at a flow of 250 nL/min. The nano LC gradient
consisted of a linear gradient starting at 5 % of 90 %
ACN, 0.1 % FA (buffer B) and ramping to 40 % buffer B
over 45 min (0–45 min). In half a minute the gradient
was ramped to 90 % buffer B (45–45.5 min) and held for
6 min (45.5-51.5 min.) followed by ramping to 5 % buf-
fer B for 3.5 min (51.5-55 min) and equilibration of the
column in 15 min (55–70 min). The Collision energy
(CE) for each peptide was calculated according to the
following formulas; CE = 0.044 x m/z +10 for doubly
charged precursors and CE = 0.05 x m/z + 9 for triply
precursors. The SRM data was analyzed using Skyline
v1.4 [87] using the most abundant transition for quantifi-
cation. Student's t-test was used to calculate the p-value
between sample groups.
Glutathione-S-transferase (GST) assay
GSTactivity was determined according to a previously pub-
lished method [88]. GST activity per min per mg protein
was calculated for each sample in control (n = 10),
0.5 mg/kg BW MeHg (n = 9) and 2 mg/kg BW MeHg
(n = 9) groups. Treated and control groups were com-
pared using Student’s t-test.
Annotation, pathway and gene ontology enrichment
analysis
Enrichment analyses for MetaCore “Process Networks”
and GO (Biological Processes and Molecular Functions)
were performed in MetaCore™ (MetaCore™; GeneGo-
Thomson Reuters, St. Joseph, MI). A false discovery rate
(FDR) < 0.05 was used as the threshold for significant
enrichment.
Network analysis, enrichment and visualization
Gene ontology pathway enrichment analysis and net-
work visualization was performed using Cytoscape
v3.2.1 (http://www.cytoscape.org/) with the plug-ins
ClueGo v2.1.7 [89] and CluPedia v1.1.7 [72], at FDR <
0.05. GO (BP and MF) and KEGG, REACTOME and
WikiPathways databases were used. Protein-protein
interaction network and KEGG pathway, GO and
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protein domain enrichment analyses were performed in
STRING v10 [90].
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2 mg/kg BW MeHg (2 mg) treated Atlantic cod; Figure S2. Histograms
illustrating the label-free quantification data. Average abundance of each
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BW MeHg (green line) group (Graph Pad Prism using auto bin range and
width); Figure S3. SRM-quantification of differential expression for the
proteins APOA4, represented by three peptides (A-C), and CATZ (D);
Figure S4 - STRING protein-protein interaction network of differentially
regulated proteins; Figure S5. Venn diagram showing shared annotations
between proteomics and transcriptomics datasets; Figure S6. Networks
of combined differentially regulated genes identified in transcriptomics
and proteomics analyses in MeHg treated samples; Figure S7. Venn
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BW MeHg (n = 9) fish. (XLSX 610 kb)
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BP and MF and all significant MetaCore processes network terms and the
associated proteins. (XLSX 73 kb)
Additional file 5: Table S4. Full list of significantly enriched KEGG, GO
(BP, MF and CC) and Interpro protein domains from STRING network
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